Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca plc    AZN   GB0009895292

Delayed Quote. Delayed  - 08/30 12:35:18 pm
4987 GBp   +0.65%
08/25 ASTRAZENECA : to divest part of antibiotics business in up to $1.5 b..
08/25 FTSE retreats as pharma stocks fall
08/25 Astra in £1.2bn deal with Pfizer
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

AstraZeneca Buys Back 318283 Shares

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/30/2012 | 12:23pm CEST

AstraZeneca PLC (>> AstraZeneca plc) said Monday it has purchased 318,283 ordinary shares on April 27 at a price of 2666 pence per share for cancellation.

-Shares at 1005 GMT up 1%, at 2704 pence, valuing the company at GBP34 billion.

-By Mark Shapland, Dow Jones Newswires; +44 207 8429358; mark.shapland@dowjones.com

Stocks mentioned in the article : AstraZeneca plc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ASTRAZENECA PLC
08/25 ASTRAZENECA : to divest part of antibiotics business in up to $1.5 billion deal
08/25 FTSE retreats as pharma stocks fall
08/25 Astra in £1.2bn deal with Pfizer
08/25DJPFIZER : to Buy Some Of Astra's Antibiotics -- WSJ
08/25 Pfizer snaps up AstraZeneca's antibiotics arm
08/25 ASTRAZENECA : *berenberg cuts astrazeneca price target to 5550 pence - 'buy'
08/25 ASTRAZENECA : sells off drugs to Pfizer
08/24 ASTRAZENECA : Pfizer met la main sur 60 anti-infectieux et antifongiques pour 1,..
08/24 Pfizer on buying spree with AstraZeneca antibiotics deal
08/24 PFIZER : AstraZeneca to sell antibiotic pills business to Pfizer
More news
Sector news : Pharmaceuticals - NEC
08:49aDJBusiness Watch -- WSJ
08/29 Mylan to launch generic EpiPen at half the price of original
08/29DJMondelez Walks Away After Hershey Spurns Raised Bid
08/29DJROCHE : Receives US FDA Emergency Use Authorization for Zika Test -- Update
08/29DJROCHE : Receives US FDA Emergency Use Authorization for Zika Test
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/29 BIOTECH FORUM DAILY DIGEST : Mylan Adjusts Course, Who Is Next Midcap Buyout Tar..
08/26 A Merck Versus Bristol Showdown
08/26 BIOTECH FORUM DAILY DIGEST : Clinton Takes A Swipe At Biotech, Revisiting The Bu..
08/26 Updating My Price Target On Pfizer
08/25 PFIZER AND MEDIVATION : A Good Strategic Fit
Advertisement
Financials ($)
Sales 2016 23 169 M
EBIT 2016 5 728 M
Net income 2016 2 609 M
Debt 2016 11 639 M
Yield 2016 4,35%
P/E ratio 2016 32,17
P/E ratio 2017 29,31
EV / Sales 2016 7,99x
EV / Sales 2017 8,17x
Capitalization 173 471 M
More Financials
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca plc Technical Analysis Chart | AZN | GB0009895292 | 4-Traders
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 69,1 $
Spread / Average Target 6,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Dunoyer Chief Financial Officer & Executive Director
Edward Bradley Senior VP-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC7.33%173 471
JOHNSON & JOHNSON16.74%328 086
PFIZER INC.8.77%212 965
ROCHE HOLDING LTD.-12.84%212 954
NOVARTIS AG-10.83%208 887
MERCK & CO., INC.19.29%174 236
More Results